Eton Pharmaceuticals, Inc. (ETON)
18.20
-0.02
(-0.11%)
USD |
NASDAQ |
Feb 20, 14:12
Eton Pharmaceuticals EPS Diluted (Quarterly) : -0.0716 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1621 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.927M |
| Revenue (Quarterly) | 22.46M |
| Total Expenses (Quarterly) | 24.39M |
| Enterprise Value | 482.37M |
| Gross Profit Margin (Quarterly) | 34.97% |
| Profit Margin (Quarterly) | -8.58% |
| Earnings Yield | -1.37% |
| Normalized Earnings Yield | -1.239 |